6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Digitale Gesundheitsanwendungen (DiGA): Patientenzentrierte Gesundheitsversorgung mit disruptivem Potenzial Translated title: Digital health applications—patient-centric care with disruptive potential

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Digitale Gesundheitsanwendungen (DiGA) kommen als Versprechen, die Patientenversorgung kosteneffizient zu verbessern. Patientennetzwerke sind häufig Ansprechpartner, wenn DiGA entwickelt oder in der Praxis getestet werden sollen. Das Netzwerk für Melanomerkrankte „Melanoma Patient Network Europe“ (MPNE) hat hierbei wertvolle Einblicke in die Grundvoraussetzungen für erfolgreiche DiGA gewonnen: Validierte Ausgangshypothesen, Wertschöpfung durch vertikale Integration, verantwortungsvolle Finanzierungsmodelle und Datensicherheit. Dieser Artikel beschreibt aus Patientenvertretersicht den breiteren digitalen Kontext, in dem sich DiGA befinden, und diskutiert das disruptive Potenzial dieser Anwendungen, die es Patient:innen zunehmend erlauben, bedarfsgerechte Versorgung einzufordern.

          Translated abstract

          Digital applications, or “DiGA” in German, come with the promise of cost-effective interventions to improve patient care. Patient networks are frequently approached when DiGA are developed or need to be tested in a real-world setting. The network of those affected by melanoma, the “Melanoma Patient Network Europe” (MPNE), has thereby gained valuable insights into the fundamental characteristics of successful DiGA: a validated initial hypothesis, value generation through vertical integration, responsible financing models and data security.

          This article provides a patient advocacy perspective on the wider digital context in which DiGA exists and reflects on the disruptive potential as these applications enable patients to increasingly impose their preferences with regards to their own care.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study

          Background: Non-adherence to corticosteroid treatment has been shown to reduce treatment efficacy, thus compromising asthma control. Aims: To examine the experiences of treatment side effects, treatment concerns and adherence to inhaled (ICS) and oral corticosteroids (OCS) among people with asthma and to identify the degree of concordance between clinician estimates of side effects and the prevalence reported by patients. Methods: Asthma UK members were sent validated questionnaires assessing treatment concerns, experiences of side effects and adherence. Questionnaires measuring clinicians’ estimates of the prevalence of corticosteroid side effects were completed online. Results: Completed questionnaires were returned by 1,524 people taking ICS, 233 taking OCS and 244 clinicians (67% of clinicians were primary care nurses). Among people with asthma, 64% of those taking ICS and 88% of those taking OCS reported ⩾1 side effect. People reporting high adherence to ICS (t=−3.09, P<0.005) and those reporting low adherence to OCS (t=1.86, P<0.05; one-tailed test) reported more side effects. There was a disparity between clinicians’ estimates of the frequency of side effects and the frequency reported by people with asthma: e.g., although 46% of people taking ICS reported sore throat, clinicians estimated that this figure would be 10%. Patients who reported side effects had stronger concerns about both ICS (r=0.46, P<0.0001) and OCS (r=0.50, P<0.0001). Concerns about corticosteroids were associated with low adherence to ICS (t=6.90, P<0.0001) and OCS (t=1.71; P<0.05; one-tailed test). Conclusions: An unexpectedly large proportion of people with asthma experienced side effects and had strong concerns about their treatment, which compromised adherence. These findings have implications for the design of interventions to optimise asthma control through improved adherence.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Consumer reporting of adverse drug reactions : Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care

            Many countries have established systems that allow patients to report adverse drug reactions directly, complementing the reports from healthcare professionals. Experience with these systems has shown that direct consumer reporting on drug side effects provides valuable information for public health and healthcare authorities.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Factors Predicting Intentional Non-adherence in Chronic Myeloid Leukemia: A Multivariate Analysis on 2546 Patients by the CML Advocates Network

                Bookmark

                Author and article information

                Contributors
                bettina.ryll@mpneurope.org
                Journal
                Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
                Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
                Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1436-9990
                1437-1588
                3 September 2021
                : 1-6
                Affiliations
                Melanoma Patient Network Europe, 75597 Uppsala, Schweden
                Article
                3421
                10.1007/s00103-021-03421-x
                8414020
                34477883
                679a7137-69c7-462d-9c5f-18b11b9307da
                © Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 26 July 2021
                : 26 August 2021
                Categories
                Leitthema

                digitale anwendungen,patientenzentrierte gesundheitsversorgung,limitationen,disruptives potenzial,patientenvertretung,digital application,patient-centred care,limitations,disruptive potential,patient advocacy

                Comments

                Comment on this article